Marcan Pharmaceuticals to invest CAD $50 million in Mantra Pharma Inc.

Emcure Pharmaceuticals announced that Marcan Pharmaceuticals Inc., a subsidiary of the Company (Marcan) has on 02 July 2026 (EDT) entered into share purchase agreements with certain shareholders of Mantra Pharma Inc., a step-down subsidiary of the Company (Mantra), to acquire all of Class E Special Shares in the share capital of Mantra for an aggregate consideration of CAD $ 50 million. Consequently, Mantra continues to be 100% subsidiary of Marcan.

Mantra Pharma Inc., a company incorporated under the laws of Quebec, Canada, is engaged in the marketing and distribution of prescription drugs and natural health products.